nystatin-a1 and Penile-Diseases

Candicidin for treatment of vaginal candidiasis is discussed. Candicidin has not been established as being superior to nystatin for cure or relief of monilial vaginal infections. Since nystatin has been in use for years with only minor adverse affect and since it is less exp ensive than candicidin, it should still be the drug of choice. If 1 or 2 courses of intravaginal and oral nystatin fail to cure (as tested by culture), candicidin is worth trying. Unlike mystatin, candicidin is not available in an oral formulation. Many "Medical Letter" consultants believe that cur of vaginal candidiasis is easier if patients stop taking oral contraceptives when the diagnosis is made.

Topics: Administration, Oral; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Contraceptives, Oral; Costs and Cost Analysis; Evaluation Studies as Topic; Female; Humans; Male; Nystatin; Ointments; Penile Diseases; Tablets